# GPT 5.2 Review - Reviewer 1/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T14:27:21.560291
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_004bcb03e52cf02a00697b5f87f8848193884078c5bd12bbff
**Tokens:** 18082 in / 5557 out
**Response SHA256:** 472a9a4a56ccd0c8

---

## Referee Report — “Roads, Crashes, and Substances: A Geocoded Atlas of Western US Traffic Fatalities” (Jan 29, 2026)

### Summary
This manuscript is primarily a **data-infrastructure + descriptive visualization** paper: it constructs an integrated crash-level dataset (FARS + OSM + marijuana policy timing) for Western states and presents descriptive patterns and maps, with an eye toward enabling spatial RDD and other quasi-experimental designs.

As written, the paper is **not publishable in a top general-interest economics journal or AEJ: Economic Policy**, because it **does not conduct statistical inference**, does not estimate causal effects, and does not meet basic empirical standards expected for policy claims. If the target outlet is truly AER/QJE/JPE/ReStud/Ecta/AEJ:EP, the paper must be reframed and rebuilt around a credible identification strategy with full inference and robustness, and the dataset construction must support that empirical design (including continuous years, pre-trends, and testing/measurement issues).

---

# 1. FORMAT CHECK

### Length
- The PDF shown runs to **~29 pages total**, but the **main text ends around p. 24**, with references on pp. 25–26 and appendices thereafter.
- **Requirement** (your checklist): at least **25 pages excluding references/appendix**.  
  **Status: FAIL (borderline but likely under 25 pages of main text).** You need either a longer main text or to move substantive content out of appendix and into the main paper.

### References
- The bibliography is **thin** relative to the scope and claims. It cites a small set of DiD/RDD references and a couple of marijuana papers, but **misses major foundational work** (DiD, RDD, border designs, FARS measurement/testing, marijuana-traffic safety literature).
- **Status: FAIL for a top journal.** (Details and BibTeX below in Section 4.)

### Prose vs. bullets
- Most narrative sections are paragraph-form. Bullets appear mainly in Data/Appendix variable definitions (appropriate).
- However, some “data infrastructure” lists in Section 2 are fine; the issue is not bullets per se, but rather that the core “results” sections are **descriptive narration without econometric content**.

### Section depth (3+ substantive paragraphs per major section)
- Several sections are **too thin**, with 1–2 paragraphs (e.g., 3.1–3.3; 4.x map subsections; parts of 6). For top journals, the empirical sections typically need more structured exposition, interpretation, and robustness discussion.
- **Status: FAIL/Needs work.**

### Figures
- Time-series/bar figures have axes and visible data (e.g., Figs 1–4).
- Many **maps do not have axes** (common and acceptable) but should have: clear scale bars (you sometimes do), north arrows (optional), consistent legends, and—crucially—**bin definitions / denominators** for rate maps/plots.
- Figures 5–8 are visually legible, but for publication they need more explicit notes on the sample restriction (e.g., “crashes with any drug record,” “drivers only,” etc.) and how “THC finding” is defined.
- **Status: mostly OK, but not publication-quality yet.**

### Tables
- Tables shown contain actual numbers (Table 1, Table 2).
- Table 2 has a labeling issue: “Panel D” appears after Panel B, and “Panel C” after Panel D—panel ordering is confusing.
- **Status: PASS with fixes.**

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

Your own instructions correctly state: **a paper cannot pass without proper statistical inference.** On that criterion:

### a) Standard errors
- There are **no regressions** and therefore **no coefficients with SEs** anywhere.
- Even the border/RDD-style plots are descriptive (LOESS curves), not estimates with robust bias-corrected inference.
- **Status: FAIL.**

### b) Significance testing
- There are **no hypothesis tests** (no p-values, permutation/randomization inference, placebo borders, etc.).
- **Status: FAIL.**

### c) Confidence intervals
- No 95% CIs for any “main result” (e.g., the ~20% vs ~10% THC share).
- **Status: FAIL.**

### d) Sample sizes
- N is sometimes reported in figure captions (good), but there are **no regression Ns** because there are no regressions.
- The descriptive denominators are often unclear (e.g., “crashes with any drug record,” but what fraction of all fatal crashes is that by state-year-border bin?).
- **Status: FAIL for regression standards; partial PASS for descriptives.**

### e) DiD with staggered adoption
- You *discuss* DiD (Section 8.2) and correctly note missing years preclude event studies. But you do not implement any DiD.
- Also, your state grouping sometimes uses “eventual legalization status” rather than crash-date policy (e.g., Fig 3 note)—this is not an acceptable treatment definition for causal inference.
- **Status: FAIL (not implemented).**

### f) RDD requirements (bandwidth, McCrary, sensitivity)
- You *motivate* spatial RDD, show maps and an RDD-style plot (Fig 15), but do not implement:
  - local polynomial estimation with optimal bandwidth,
  - bandwidth sensitivity,
  - covariate continuity checks,
  - McCrary-style density/manipulation (or spatial analog),
  - donut-hole checks around the border line,
  - border-segment fixed effects / pair-specific designs.
- **Status: FAIL.**

**Bottom line on methodology:** As written, this manuscript is **unpublishable** in the listed outlets. Descriptive mapping + dataset documentation can be valuable, but top econ policy outlets still require either (i) a clearly scoped “data” contribution with rigorous validation and benchmarking, or (ii) a causal analysis with full inference. You currently provide neither.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- There is **no executed identification strategy**. The paper repeatedly uses causal language (“consistent with legalization increasing THC involvement…”) based on cross-sectional differences (e.g., Section 3.2; Section 6.2). This is **not credible** absent a research design and inference.

### Assumptions
- You mention key assumptions at a high level (continuity at borders; selection into drug reporting), but you do not test or operationalize them.
- For spatial RDD, the biggest threats are:
  1. **border sorting in travel patterns** (crashes are outcomes of trips, not residents),
  2. **differential enforcement/testing/reporting** across states precisely because of legalization,
  3. **endogenous mobility to retail** (cross-border cannabis shopping),
  4. **different road networks/traffic volumes** at border crossings.
- These are acknowledged partially (Section 7), but not handled empirically.

### Placebos & robustness
- None. At minimum for a border design you need:
  - placebo outcomes (e.g., weather-related crash features),
  - placebo borders (borders without policy discontinuities),
  - pre-period placebo discontinuities (requires adding 2006–2017, at least for alcohol outcomes),
  - covariate continuity around borders,
  - sensitivity to bandwidth and to excluding border crossings/highways.

### Conclusions vs evidence
- The statement that the patterns are “consistent with legalization increasing THC involvement” is too strong given:
  - selected denominator (“any drug record reported”),
  - THC detectability vs impairment,
  - heterogeneous testing/reporting regimes.
- You should rewrite much of the Results/Discussion in **strictly descriptive language**, unless and until you implement a causal design.

### Limitations
- Section 7 is the strongest part conceptually: it correctly emphasizes FARS drug reporting limitations and the THC impairment/detection gap. This is good, but top outlets will expect you to go further and propose/implement correction strategies.

---

# 4. LITERATURE (MISSING REFERENCES + BibTeX)

## 4.1 Methods: DiD (staggered adoption, diagnostics, inference)
You cite Callaway & Sant’Anna (2021) and Sun & Abraham (2021), but you omit several “must-cite” references for modern DiD practice and diagnostics:

1) **Goodman-Bacon (2021)** — TWFE decomposition and why naïve TWFE fails under staggered treatment.  
2) **Borusyak, Jaravel & Spiess (2021)** — imputation estimator; widely used alternative.  
3) **de Chaisemartin & D’Haultfoeuille (2020)** — TWFE can be biased; provides alternative estimators.  
4) **Roth (2022)** — pre-trends testing and sensitivity analysis.

```bibtex
@article{GoodmanBacon2021,
  author  = {Goodman-Bacon, Andrew},
  title   = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year    = {2021},
  volume  = {225},
  number  = {2},
  pages   = {254--277}
}

@article{BorusyakJaravelSpiess2021,
  author  = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title   = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2108.12419},
  year    = {2021}
}

@article{deChaisemartinDHaultfoeuille2020,
  author  = {de Chaisemartin, Cl{\'e}ment and D'Haultfoeuille, Xavier},
  title   = {Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects},
  journal = {American Economic Review},
  year    = {2020},
  volume  = {110},
  number  = {9},
  pages   = {2964--2996}
}

@article{Roth2022,
  author  = {Roth, Jonathan},
  title   = {Pretest with Caution: Event-Study Estimates after Testing for Parallel Trends},
  journal = {American Economic Review: Insights},
  year    = {2022},
  volume  = {4},
  number  = {3},
  pages   = {305--322}
}
```

## 4.2 Methods: RDD (foundations + implementation standards)
You cite Keele & Titiunik (2015), but omit foundational and implementation papers that are standard in top outlets:

1) **Imbens & Lemieux (2008)** and/or **Lee & Lemieux (2010)** — canonical RDD guides.  
2) **McCrary (2008)** — density test (manipulation).  
3) **Calonico, Cattaneo & Titiunik (2014)** — robust bias-corrected inference.  
4) **Cattaneo, Idrobo & Titiunik (2020/2021)** — practical RDD and robust inference.

```bibtex
@article{ImbensLemieux2008,
  author  = {Imbens, Guido W. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {615--635}
}

@article{LeeLemieux2010,
  author  = {Lee, David S. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year    = {2010},
  volume  = {48},
  number  = {2},
  pages   = {281--355}
}

@article{McCrary2008,
  author  = {McCrary, Justin},
  title   = {Manipulation of the Running Variable in the Regression Discontinuity Design: A Density Test},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {698--714}
}

@article{CalonicoCattaneoTitiunik2014,
  author  = {Calonico, Sebastian and Cattaneo, Matias D. and Titiunik, Rocio},
  title   = {Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs},
  journal = {Econometrica},
  year    = {2014},
  volume  = {82},
  number  = {6},
  pages   = {2295--2326}
}
```

## 4.3 Border discontinuity / spatial RDD practice
Given your emphasis on borders, you should engage the broader “border RD” literature beyond Keele & Titiunik, including canonical economics applications and best practices (e.g., segmenting borders, dealing with spatial correlation, road network discontinuities). Examples include Dell (2010) style boundary work, and applied “border designs” in regional/public economics.

```bibtex
@article{Dell2010,
  author  = {Dell, Melissa},
  title   = {The Persistent Effects of Peru's Mining Mita},
  journal = {Econometrica},
  year    = {2010},
  volume  = {78},
  number  = {6},
  pages   = {1863--1903}
}
```

(You do not need Dell specifically, but you need **some** set of established border-discontinuity references and a discussion of spatial correlation/inference.)

## 4.4 Marijuana legalization and traffic safety literature (domain)
The paper’s policy framing is marijuana legalization and fatalities, yet the citations are limited (Anderson et al. 2013; Hansen et al. 2015—note: Hansen et al. 2015 cited is about teen use, not traffic). You need to cite:
- empirical work on recreational legalization and crashes/fatalities,
- work on THC testing and impairment measurement,
- policy evaluation papers using FARS in related contexts.

Examples (illustrative; you should curate the best set):
- Aydelotte et al. on fatal crash trends post-legalization (medical/public health literature; you must engage it even if not econ).
- Santaella-Tenorio et al. review on cannabis policy and health/safety outcomes.
- Hartman & Huestis on cannabis impairment/testing.

```bibtex
@article{HartmanHuestis2013,
  author  = {Hartman, Rebecca L. and Huestis, Marilyn A.},
  title   = {Cannabis Effects on Driving Skills},
  journal = {Clinical Chemistry},
  year    = {2013},
  volume  = {59},
  number  = {3},
  pages   = {478--492}
}

@article{SantaellaTenorio2017,
  author  = {Santaella-Tenorio, Julio and Mauro, Christine M. and Wall, Melanie M. and Kim, Ji Hyun and Cerda, Magdalena and Keyes, Katherine M. and Hasin, Deborah S. and Martins, Silvia S.},
  title   = {US Traffic Fatalities, 1985--2014, and Their Relationship to Medical Marijuana Laws},
  journal = {American Journal of Public Health},
  year    = {2017},
  volume  = {107},
  number  = {2},
  pages   = {336--342}
}
```

If you want to publish in econ, you must (i) cite this literature, and (ii) explain precisely how your dataset improves on it (geocoding + road attributes + border designs), and then (iii) actually implement the promised designs.

---

# 5. WRITING QUALITY (CRITICAL)

### a) Prose vs bullets
- Generally acceptable: Introduction and narrative sections are paragraphs.
- However, the paper reads more like a **technical report / project documentation** than a top-journal article. In top outlets, even “data” papers are written with a tight argumentative arc and explicit validation/benchmarking.

### b) Narrative flow
- The Introduction (pp. 1–2) has a standard structure, but the hook is generic and the central contribution is not sharply differentiated from “we merged datasets and made maps.”
- The promised payoff is “enables unprecedented granularity” and “motivates spatial RDD,” but the paper does not deliver an estimation exercise. That creates a mismatch between narrative and content.

### c) Sentence quality
- Prose is generally clear, but repetitive (“This motivates… enables…”). Too many claims are framed as findings (“consistent with legalization increasing…”) without the empirical scaffolding.

### d) Accessibility
- The FARS drug testing/reporting limitation is explained clearly (Section 2.1 and Section 7). That is good.
- But key denominators and selection are still easy to misunderstand. Many readers will incorrectly interpret your “THC-positive rate among crashes with drug records” as a population rate. You must foreground this limitation more aggressively in the Results section itself, not only in limitations.

### e) Figures/Tables quality
- Plots have decent labeling, but **policy/treatment definitions** are inconsistent (e.g., grouping CA/NV as “legal states” even in 2016 when they were not legal; Fig 3 note). That is acceptable for a purely descriptive “eventual adopter” comparison, but then you must not use causal language and must rename the groups to avoid confusion.

---

# 6. CONSTRUCTIVE SUGGESTIONS (HOW TO MAKE THIS TOP-JOURNAL-READY)

You have two viable pathways. Right now you are stuck between them.

## Path A: Make it a true “Data + Validation” paper (still hard in AER/QJE/etc.)
To have a chance as a “data infrastructure” contribution in a top outlet, you need:
1) **External validation / benchmarking**:
   - Compare OSM road attributes to authoritative sources (HPMS, state DOT functional class, speed limit databases) on a matched sample.
   - Quantify snapping error, misclassification rates, and how they vary by rurality/state/road type.
2) **Representativeness diagnostics**:
   - Show how geocoded vs non-geocoded crashes differ.
   - Show how “drug-record-present” vs absent differ, by state-year and by observables, and how that correlates with legalization.
3) **A measurement model for THC**:
   - At minimum, treat THC detection as a mismeasured proxy for impairment and present sensitivity/bounds.
   - Consider bounding exercises (e.g., worst/best-case under differential testing/reporting).
4) **Open, reusable data product**:
   - A stable schema, versioning, DOI, and replication that runs end-to-end without manual intervention.
   - Clear licensing and data provenance.

Even with all this, top econ outlets may still view it as “tooling” unless it delivers a novel economic insight.

## Path B (recommended): Add a real causal analysis that uses the new data
If you want AEJ:EP / ReStud / AER-style acceptability, you need a **flagship empirical design** with full inference, and the dataset is the enabling contribution.

### (i) Spatial RDD at borders — what you must do
- Use **local polynomial RD** with robust bias-corrected inference (Calonico et al.).
- Specify:
  - running variable: signed distance to border (with careful projection),
  - bandwidth selection,
  - kernel and polynomial order.
- **Inference**:
  - 95% CIs, robust SEs, and address spatial correlation (Conley SEs or clustering at border-segment × time).
- **Validity checks**:
  - density test adapted to spatial setting (McCrary-style on distance distribution),
  - covariate continuity (weather, time-of-day, road class, urbanicity, etc.),
  - donut hole around the border line,
  - placebo borders (e.g., borders between two illegal states, or pre-period discontinuities in alcohol outcomes),
  - border-pair heterogeneity with pre-analysis plan style discipline (you already show heterogeneity in Fig 14).

### (ii) DiD/event study — your data currently prevent this; fix it
- The missing 2006–2015 years are fatal to any credible legalization event study.
- Extend the pipeline to **2001–2019 continuously** (or 2008–2023 if available).
- Then implement:
  - Callaway & Sant’Anna (group-time ATTs) with never-treated or not-yet-treated controls,
  - Sun & Abraham interaction-weighted event study,
  - report pre-trends tests and sensitivity (Roth 2022).

### (iii) Outcomes: don’t hang everything on “THC detected”
Given the THC impairment/detection problem and reporting selection, consider outcome sets that are less fragile:
- fatal crash counts per VMT (requires exposure data),
- nighttime single-vehicle crashes (classic impairment proxy),
- alcohol-involved crashes (more reliably measured),
- drug-record reporting itself as an outcome (testing/regime change).

### (iv) Deal head-on with selection into drug reporting
At minimum:
- show state-year drug-record rates and how they change with legalization,
- implement inverse probability weighting using observables predicting drug-record presence,
- conduct sensitivity analyses under differential selection (simple bounds).

### (v) Treatment definition must be coherent
- Define treatment at **crash date** (rec legal; retail open), not “eventual legalizer.”
- For borders, define treatment based on the legal regime of the state on that date.
- If you restrict to 2018–2019, explain why that window is informative and how generalizable it is.

---

# 7. OVERALL ASSESSMENT

### Key strengths
- The integrated dataset idea is useful and potentially enabling.
- The paper is transparent about major FARS drug-measurement limitations (Sections 2.1 and 7).
- The mapping vignettes (Colorado–Wyoming, I-25 corridor) convincingly show the **granularity** of the geocoding and suggest feasible border designs.

### Critical weaknesses (publication-stoppers)
1) **No statistical inference** (no regressions, no SEs/CIs/tests).  
2) **No implemented identification strategy** despite repeated motivation of RDD/DiD.  
3) **Causal-leaning language** based on cross-sectional descriptives with severe selection concerns.  
4) **Incomplete literature positioning** for both methods and domain.  
5) **Data gaps (2006–2015)** undermine the main policy question if the goal is legalization effects.

### Specific, high-priority fixes
- Decide whether this is (A) a data-validation paper or (B) a causal policy paper—and then meet that genre’s standards.
- If (B), add continuous years and implement a full border RD and/or modern DiD with complete inference and validity checks.
- Rewrite claims to match evidence; avoid implying causal effects without design + inference.

---

DECISION: REJECT AND RESUBMIT